The Iran-Israel conflict and potential Strait of Hormuz disruption are creating supply chain pressures on medical supplies through petrochemical derivatives. Key inputs like naphtha and methanol used in pharmaceutical packaging and drug synthesis are experiencing price increases. While hospitals haven't yet felt the impact, analysts expect cost pressures on IV bags, tubing, and other critical consumables to surface within 2-4 weeks as the disruption ripples through supply chains.

The global IV solutions market is projected to grow from USD 13.35 billion in 2025 to USD 29.47 billion by 2035, with a CAGR of 8.24%. Growth is driven by increasing prevalence of chronic diseases, rising hospital admissions, and growing demand for parenteral nutrition and critical care solutions. The U.S. market alone is expected to reach USD 8.39 billion by 2035. North America leads with 40.70% market share, while Asia-Pacific shows the fastest growth at 9.46% CAGR.

The global intravenous infusion pump market was valued at USD 6.72 billion in 2025 and is projected to reach USD 14.02 billion by 2035, growing at a CAGR of 7.6%. Growth is driven by increasing chronic diseases, aging populations, technological advancements in smart pumps, and rising demand for precise medication delivery in hospitals and home care settings.

ICU Medical reported Q2 2025 earnings with a significant EPS beat of $2.10, exceeding analyst expectations by 40%. Despite strong profitability, the company faces challenges from regulatory issues, tariffs, and segment performance variability, leading to cautious FY2025 guidance.

The global IV hydration therapy market is expected to grow from $2.51 billion in 2024 to $3.94 billion by 2030, driven by the increasing incidence of chronic illnesses, rising surgical volumes, and the growing number of intravenous drug approvals. Technological advancements and personalized solutions are also boosting consumer demand for home-based, individualized care.

Bragar Eagel & Squire, P.C. is investigating potential claims against Organon, Aldeyra, Landstar, and ICU Medical due to issues related to financial results, regulatory matters, and accounting fraud.

The global blood pressure monitor market is projected to grow from USD 2.40 billion in 2025 to USD 4.36 billion by 2035, driven by aging populations, home healthcare, and AI-powered wearables. The rising prevalence of hypertension and technological advancements are key factors driving the market growth.

The operating room equipment market is experiencing strong growth, driven by the increasing volume of surgical procedures and the growing incidence of chronic diseases, particularly among the aging population. North America is expected to dominate the market, with technological advancements and investments in research and development by key players fueling the demand for cutting-edge operating room equipment.

The patient temperature management market is expected to grow from $3.1 billion in 2023 to $6.5 billion by 2035, driven by an increase in surgical procedures, government initiatives, and technological advancements. However, the high cost of devices is a restraint.

The global infusion devices market is expected to grow significantly due to the increasing prevalence of cancer and strategic initiatives by market players, reaching $23.08 billion by 2031.

The global medical cannula market is expected to grow significantly, reaching $447 million by 2034, driven by increasing healthcare access, technological advancements, and an aging population. The demand for minimally invasive and patient-friendly cannula devices is set to rise, driving innovation in the market.

The global closed system transfer device market is projected to grow from $1.1 billion in 2024 to $4.8 billion by 2034, driven by advancements in technology and increasing cancer cases worldwide.